Results 61 to 70 of about 2,707 (196)

Assessing the predictive value of intraductal carcinoma of the prostate (IDC‐P) in determining abiraterone efficacy for metastatic hormone‐sensitive prostate cancer (mHSPC) patients

The Prostate, Volume 85, Issue 2, Page 130-139, February 2025.
Abstract Background This study explored the value of intraductal carcinoma of the prostate (IDC‐P) in predicting the efficacy of abiraterone treatment in metastatic hormone‐sensitive prostate cancer (mHSPC) patients. Methods A retrospective study of 925 patients who underwent prostate biopsies to detect IDC‐P was conducted, with participants divided ...
Xinyuan Wei, Jinge Zhao, Ling Nie, Yifu Shi, Fengnian Zhao, Yu Shen, Junru Chen, Guangxi Sun, Xingming Zhang, Jiayu Liang, Xu Hu, Pengfei Shen, Ni Chen, Hao Zeng, Zhenhua Liu   +14 more
wiley   +1 more source

The value of touch imprint cytology of prostate core needle biopsy specimens – Kuwait experience

African Journal of Urology, 2015
Objectives: Touch imprint cytology (TIC) is a reliable, cost-effective technique for the diagnosis of cancer. The aim of this study was to determine the diagnostic value and accuracy of TIC of prostate core needle biopsy (CNB) specimens in predicting the
S. Hussein, K. Kapila, I.M. Francis, S.S. George, E.O. Kehinde   +4 more
doaj   +1 more source

Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity [PDF]

, 2010
Background The serine/threonine kinase PIM1 has been implicated as an oncogene in various human cancers including lymphomas, gastric, colorectal and prostate carcinomas.
Jongchan Kim, Meejeon Roh, Sarki A Abdulkadir, KC Qian, T Mochizuki, Z Wang, M Bachmann, D Morishita, N Bhattacharya, TL Aho, JJ Gu, N Shah, H Akasaka, EA Sivertsen, L Pasqualucci, G Gaidano, M Libra, M Montesinos-Rongen, M van Lohuizen, M Breuer, T Moroy, SM Dhanasekaran, K Ellwood-Yen, WW Chen, M Roh, J Kim, M Roh, M Roh, G Carlsson, IL Cameron, SA Abdulkadir, D Bello, JS Horoszewicz, JS Horoszewicz, DD Mickey, KR Stone, DD Mickey, J Thompson, O Kim, Y Zhang, A Zippo, X Yin, MJ Huang, CP Lin, A Valdman, TL Cibull, J Wang, J Guo, H Wang   +48 more
core   +1 more source

DNA Methylation in Prostate Cancer: Clinical Implications and Potential Applications

Cancer Medicine, Volume 14, Issue 1, January 2025.
ABSTRACT Background Prostate cancer is a common cancer with a variable prognosis. Its management is currently guided by histological and biological markers such as the Gleason score and PSA. Developments in molecular biology are now making it possible to identify new targets for better classification of prostate cancer.
Romane Muletier, Céline Bourgne, Laurent Guy, Aurore Dougé   +3 more
wiley   +1 more source

ERG expression in prostate cancer biopsies with and without high-grade prostatic intraepithelial neoplasia: a study in Jordanian Arab patients

Research and Reports in Urology, 2019
Najla Aldaoud,1,2 Ashley Graboski-Bauer,3 Nour Abdo,4 Samir Al Bashir,1,2 Ashraf O Oweis,5 Hanadi Ebwaini,1 Yousef Hasen,1–2,6 Rami Alazab,7 Kiril Trpkov81Department of Pathology and Microbiology, King Abdullah University Hospital, Irbid, Jordan ...
Aldaoud N, Graboski-Bauer A, Abdo N, Al Bashir S, Oweis AO, Ebwaini H, Hasen Y, Alazab R, Trpkov K   +8 more
doaj  

The impact of metformin use on the risk of prostate cancer after prostate biopsy in patients with high grade intraepithelial neoplasia

International Brazilian Journal of Urology
Purpose We report our experience on metformin use in diabetic patients and its impact on prostate cancer (PCa) after a high-grade prostatic intraepithelial neoplasia (HGPIN) diagnosis.
Lucio Dell'Atti, Andrea B. Galosi
doaj   +1 more source

Transrectal ultrasound-guided prostate rebiopsy: How many core sampling should be applied to which patient?

Urology Annals, 2018
Background: We investigated the correlation between the sampled number of cores in rebiopsy and the cancer detection rate (CDR). Materials and Methods: Two hundred and twelve patients with normal rectal examination who had undergone rebiopsy in the past ...
Akın Soner Amasyali, Uğur Yücetaş, Erkan Erkan, Murat Demiray, Emre Karabay, Cemalettin Murat, Gökhan Toktaş, Erdinç Ünlüer   +7 more
doaj   +1 more source

Prostate cancer and the influence of dietary factors and supplements: a systematic review [PDF]

, 2007
Background Prostate cancer is the second most common cause of cancer worldwide after lung cancer. There is increasing evidence that diet and lifestyle plays a crucial role in prostate cancer biology and tumourigenesis.
Mandair, D, Rossi, R, Pericleous, M, Whyand, T, Caplin, M   +4 more
core   +2 more sources

The molecular and cellular origin of human prostate cancer [PDF]

, 2016
Prostate cancer is the most commonly diagnosed male malignancy. Despite compelling epidemiology, there are no definitive aetiological clues linking development to frequency.
Abate-Shen, Abrahamsson, Adler, Al-Hajj, Albini, Ammirante, An, An, Anderson, Anderson, Antonarakis, Ao, Armitage, Baca, Baker, Bapat, Barbieri, Barker, Barsky, Beck, Beltran, Ben-Neriah, Bergh, Bernstein, Berry, Bethel, Birkeland, Birnie, Blackwood, Bonnet, Borel, Bostwick, Bostwick, Boysen, Briganti, Bubendorf, Burkhardt, Caini, Cairns, Calabrese, Cancer Research UK, Carreira, Cesare, Chakkalakal, Chapman-Rothe, Chen, Cheshier, Choi, Chua, Clevers, Cloos, Cohen, Cohen, Collins, Collins, Conboy, Cooper, Culig, Culig, Cunha, Cunha, Dan Robinson, Das, Dawson, De Marzo, De Marzo, Dehm, Deng, Dermer, Ding, Don-Doncow, Donaldson, Dong, Ebelt, Eggener, Eminaga, Epstein, Eramo, Essers, Fang, Fassi Fehri, Fearon, Feinberg, Feng, Fialkow, Figueiredo, Foudi, Frame, Frame, Frame, Franco, Franks, Gan, Gannon, Gao, Gendrel, Gerlinger, Germann, Ghajar, Gibbs, Gimelbrant, Gleason, Gleave, Goardon, Goldstein, Gong, Goodwin, Gotay, Grasso, Grasso, Greaves, Grisanzio, Gundem, Guo, Gupta, Gurel, Guryanova, Gutierrez-Arcelus, Haapala, Haas, Haffner, Haffner, Haffner, Haffner, Hahn, Hall, Hall, Han, Hanahan, Hansel, He, Heaphy, Hecht, Heer, Herawi, Hermann, Hernandez, Heydt, Hjelmeland, Hong, Hong, Hovelson, Hrbacek, Hu, Huels, Huggins, Hurt, Hurt, Hägglöf, IACR, Iliopoulos, Iliou, Inaguma, Isaacs, Jafari, Jiao, Jin, John R. Packer, Johnston, Jones, Jones, Joseph, Karanika, Karantanos, Karthaus, Ke, Ke, Keller, Kelly, Kiel, Kim, Kooistra, Korpal, Kouzarides, Kovtun, Kreso, Krieger, Krieger, Kroon, Kulac, Kunderfranco, Lang, Lang, Lanie, Lapointe, Lark, Lavery, Lee, Lee, Leong, Leongamornlert, Li, Li, Li, Li, Lilja, Lin, Lin, Ling, Liu, Lo, Loeb, Luedeke, Lukacs, Ma, Mahmud, Maini, Maitland, Maitland, Maitland, Maitland, Mani, Marinov, Martin, Matsui, Meeker, Mehrotra, Menon, Merok, Metsalu, Metzger, Meyer, Michaud, Miyamoto, Mohan, Mounir, Munger, Nag, Nag, Nakai, Nakashima, Navarro, Nelson, Network, Nonn, Nonomura, Norman J. Maitland, Norrish, Nowell, O'Callaghan, O'Sullivan, Ohm, Olumi, Osman, Ousset, Park, Pascale, Patel, Patel, Patra, Patrawala, Patrawala, Pellacani, Penney, Perner, Perner, Perry, Peto, Pierce, Platz, Polson, Potten, Potter, Prince, Pritchard, Putzi, Qin, Rajan, Rando, Rane, Rane, Raval, Reik, Ricci-Vitiani, Ricci-Vitiani, Rich, Richardson, Riley, Risbridger, Robinson, Rodriguez, Rosa Mendoza, Ross-Adams, Roth, Ruska, Rutella, Sack, Sakr, Schiewer, Schober, Schroeder, Sfanos, Sfanos, Sfanos, Sfanos, Sharma, Sharma, Shen, Shibata, Shinohara, Shiozawa, Singh, Singh, Slaughter, Smith, Sneddon, Sommerfeld, Song, Song, Steinhauser, Stewart, Strand, Strasner, Stratton, Strickler, Sugimura, Suzuki, Tan, Tan, Tang, Taplin, Taylor, Tepper, Thompson, Ting, Ting, Toh, Tollervey, Tomasetti, Tomasetti, Tomasetti, Tomlins, Tomlins, Tomlinson, Tomlinson, Trock, True, Trumpp, Tuxhorn, Twillie, Urquidi, Ushijima, Valastyan, Van, Van Asperen, Vincent, Vindrieux, Visakorpi, Visvader, Vogelstein, Vral, Wang, Wang, Wang, Wang, Wang, Wang, Watt, Weinberger, Whitaker, Wild, Williams, Wilson, Woo, Wymenga, Xiang, Xiang, Xu, Yachida, Yamamoto, Yatabe, Yoshimoto, Yu, Zambrano, Zhang, Zhang, Zhang   +376 more
core   +1 more source

The Man Van: A pilot study of using mobile targeted case‐finding to address health inequalities in prostate cancer

International Journal of Cancer, Volume 155, Issue 12, Page 2246-2252, 15 December 2024.
What's New? Men from deprived groups are at increased risk of delayed prostate cancer diagnosis. To ease access to PSA blood testing and follow‐up for ethnic minority men and men in deprived communities, the Royal Marsden Hospital and Institute of Cancer Research in the United Kingdom initiated Man Van. Here, comparison with health screening in general
Masood Moghul, Amina Tran, Fionnuala Croft, Netty Kinsella, Clare Peckitt, Declan Cahill, Nicholas D. James   +6 more
wiley   +1 more source